Publications Database

Accordino R. E. et al. (2016)

Psychopharmacological interventions in autism spectrum disorder.

Expert Opinion on Pharmacotherapy

May, 17(7), pp. 937-952.

Read Abstract (New Window)

Aman M. G. et al. (2005)

Acute and long-term safety and tolerability of risperidone in children with autism.

Journal of Child and Adolescent Psychopharmacology

15(6), pp. 869-884

Read Abstract (New Window)

Aman M. G. et al. (2008)

Cognitive effects of risperidone in children with autism and irritable behavior.

Journal of Child and Adolescent Psychopharmacology

18(3), pp. 227-236

Read Abstract (New Window) Read Full (New Window)

Aman M. G. et al. (2009)

Medication and parent training in children with pervasive developmental disorders and serious behavior problems: Results from a randomized clinical trial.

Journal of the American Academy of Child and Adolescent Psychiatry

48(12), pp. 1143-1154

Read Abstract (New Window) Read Full (New Window)

Aman M. G. et al. (2015)

Tolerability, safety, and benefits of risperidone in children and adolescents with autism: 21-month follow-up after 8-week placebo-controlled trial.

Journal of Child and Adolescent Psychopharmacology

August, 25(6), pp. 482-493.

Read Abstract (New Window) Read Full (New Window)

Anderson G. M. et al. (2007)

Effects of short- and long-term risperidone treatment on prolactin levels in children with autism.

February, 61(4), pp. 545-550.

Read Abstract (New Window)

Arnold L. E. et al. (2000)

Assessment in multisite randomized clinical trials of patients with autistic disorder: the Autism RUPP Network.

Journal of Autism and Developmental Disorders

April, 30(2), pp. 99–111

Read Abstract (New Window)

Arnold L. E. et al. (2003)

Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials.

Journal of the American Academy of Child and Adolescent Psychiatry

42(12), pp. 1443-1450

Read Abstract (New Window)

Arnold L. E. et al. (2012)

Research Units of Pediatric Psychopharmacology (RUPP) Autism Network randomized clinical trial of parent training and medication: One-year follow-up.

Journal of the American Academy of Child and Adolescent Psychiatry

51(11), pp. 1173-1184.

Read Abstract (New Window) Read Full (New Window)

Blankenship K. et al. (2010)

Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6-17 years.

Pediatric Health

4(4), pp. 375-381

Read Abstract (New Window) Read Full (New Window)

Blankenship K. et al. (2011)

Guanfacine, extended, release, two, patients, pervasive, developmental, disorders

Journal of Child and Adolescent Psychopharmacology

21(3), pp. 287-290

Broder-Fingert S. et al. (2016)

A pilot study of autism-specific care plans during hospital admission.

Pediatrics

Read Full (New Window)

Caldwell R. L. et al. (2012)

The effects of aripiprazole on electrocardiography in children with pervasive developmental disorders.

Research in Autism Spectrum Disorders

August, 22(4), pp. 277-283.

Read Abstract (New Window) Read Full (New Window)

Carroll D. et al. (2014)

Examination of aggression and self injury in children with autism spectrum disorders and serious behavioral problems.

Child and Adolescent Psychiatric Clinics of North America

January, 23(1), pp. 57-72.

Read Abstract (New Window)

Corson A. et al. (2004)

A retrospective analysis of quetiapine in the treatment of pervasive developmental disorders.

Journal of Clinical Psychiatry

65(1), pp. 1531-1536

Read Abstract (New Window)

Dartnall N. A. et al. (1999)

Brief report: two-year control of behavioral symptoms with risperidone in two profoundly retarded adults with autism.

Journal of Autism and Developmental Disorders

29(1), pp. 87-91

Read Abstract (New Window)

Doyle C. A. , McDougle C. J. (2012)

Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.

Dialogues in Clinical Neuroscience

14(3), pp. 263-279.

Read Abstract (New Window) Read Full (New Window)

Doyle C. A. , McDougle C. J. (2012)

Pharmacotherapy to control behavioral symptoms in children with autism.

Expert Opinion on Pharmacotherapy

13(11), pp. 1615-1629.

Read Abstract (New Window)

Early M. C. et al. (2012)

Case report: 16-year-old male with autistic disorder with preoccupation with female feet.

Journal of Autism and Developmental Disorders

May, 42(6), pp. 1133-1137.

Read Abstract (New Window)

Erickson C. A. et al. (2011)

A prospective open-label study of aripiprazole in fragile X syndrome.

Psychopharmacology (Berl)

July, 216(1), pp. 85-90.

Read Abstract (New Window)